Exagen Inc. (XGN) Tops Q1 EPS by 2c

Exagen Inc. (NASDAQ: XGN) reported Q1 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $15.5 million versus the consensus estimate of $14.66 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.

You May Also Be Interested In

• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
• Western Midstream prices $700M in senior notes due 2036
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings